Overview
Retatrutide 10mg is a synthetic triple incretin receptor agonist research peptide prepared for controlled laboratory research applications. Supplied as a lyophilized powder for use in studies involving GLP-1, GIP, and glucagon receptor pathway research.
Mechanism of Action
In controlled research environments, Retatrutide has been examined in relation to triple incretin receptor activation, metabolic pathway modulation, and GPCR signaling analysis.
Receptor Interaction Profile
- GLP-1 receptor
- GIP receptor
- glucagon receptor
- triple incretin pathway models
Product Specifications
- Form: Lyophilized powder
- Strength: 10mg
- Purity: ≥98% unless otherwise specified by batch COA
- Appearance: White to off-white powder
- Use: Laboratory research only
Storage & Stability
- Store at -20°C for long-term stability
- Protect from moisture and light
- Avoid repeated freeze-thaw cycles
Research Classification
- SEO Focus Keywords: retatrutide research peptide, triple agonist, GLP-1 GIP glucagon research
Important Notice
For research use only. Not for human or veterinary use. Not evaluated by the FDA.
📖 Research Guide: Read the Retatrutide Research Guide for mechanisms, research context, and handling protocols.
Reviews
There are no reviews yet.